Redmile Group’s Nightstar Therapeutics NITE Stock Holding History
Bought
Maintained
Sold
Other funds holding NITE
Redmile Group's NITE Position: Q1 2019 in Review
Redmile Group sold out of Nightstar Therapeutics (NITE) in Q1 2019, closing a stake of 1,795,846 shares — an estimated $20.7M sold.
Redmile Group first reported a position in NITE in Q3 2017 and held it in 6 quarters. The position peaked at $42.5M in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.
- Redmile Group reported no remaining Nightstar Therapeutics position as of Q1 2019 after selling out during the quarter.
- Redmile Group sold 1,795,846 Nightstar Therapeutics shares in Q1 2019, an estimated $20.7M.
- Redmile Group first reported a position in Nightstar Therapeutics in Q3 2017 and held it in 6 quarters.
- Redmile Group's Nightstar Therapeutics position peaked at $42.5M in Q3 2018.
- 53 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q1 2019.
Based on Redmile Group's 13F filing for Q1 2019, filed 15 May 2019.